Do weight loss injections suppress your appetite — and how?

The decision most people are really facing

You've probably read that these injections "suppress appetite" and you're trying to work out whether that means you simply won't feel hungry, or whether something more fundamental shifts. It matters, because the answer shapes whether a once-weekly injection is the right fit for your life and your health history. The honest answer is: both, and neither is quite complete on its own.

Appetite is not one thing. It's a combination of physical hunger signals, food-reward motivation, the speed at which your stomach tells your brain it's full, and habitual eating patterns. GLP-1 receptor agonists like semaglutide (Wegovy) act on hypothalamic hunger circuits directly while also slowing gastric emptying, so food sits in the stomach longer before passing on. Many people describe this not as an absence of hunger but as a much earlier sense of satisfaction, eating less before feeling comfortably full. The broader effects on your body go further than appetite alone.

Tirzepatide adds a second pathway. As a dual GIP and GLP-1 receptor agonist it engages an additional gut hormone involved in insulin response and fat signalling. SURMOUNT-1, the main phase 3 trial, found average body weight reductions of around 20–21% over 72 weeks at the 15mg dose in adults with obesity, as published in the New England Journal of Medicine. Much of that reduction is explained by sustained calorie restriction driven by appetite change, but not purely by hunger suppression alone.

What the appetite change actually feels like, and when it kicks in

Clinically, the effect shows up quickly. Most people on tirzepatide or semaglutide report noticeably less preoccupation with food within the first one to two weeks, even at the starter dose. The starter dose of Mounjaro is 2.5mg, a step designed to let the body adjust before the dose is titrated upward by the prescriber. At that early stage the appetite change is usually modest. It builds over the weeks that follow each step up.

What changes specifically? People commonly describe: portions shrinking naturally without a fight; skipping snacks not because they're being disciplined but because the impulse isn't there; finishing a meal and not thinking about food again for hours. The food-noise reduction (the persistent background mental chatter about eating) is something the NHS notes as a recognised effect worth discussing with your prescriber, particularly if you have any history of disordered eating.

Side effects during early treatment are mostly gastrointestinal: nausea, fullness even with small amounts of food, occasional indigestion. These tend to settle within a couple of weeks of each dose step. NHS guidance on tirzepatide covers the full side-effect profile and explains which symptoms warrant prompt medical review. If you're also considering how treatment might affect other organs, the effect on the liver is worth reading about separately.

Is appetite suppression enough on its own, and who does this suit?

This is the question a good prescriber will help you think through. These medicines work best alongside a reduced-calorie diet and increased physical activity, the licence for both Mounjaro and Wegovy specifies this explicitly. Appetite suppression makes that combination easier to sustain, which is the real mechanism behind the trial outcomes. It doesn't replace the lifestyle component; it removes the exhausting friction from it.

Private eligibility starts at a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, prediabetes, raised cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone doesn't determine suitability; your prescriber looks at the full picture. You can explore how NHS and private routes compare on the weight loss injections from your GP page, or see the full treatment overview on the weight loss injections page.

If you're weighing up the cost of treatment alongside the clinical question, the cost breakdown for weight loss injections sets out what to expect from legitimate private providers. A clinically sound service includes the prescription, the clinical review, and (in the case of a GPhC-registered pharmacy like ours) delivery: your pen arrives via DPD in plain, unbranded packaging the next working day.

Starting the conversation with a prescriber

Appetite suppression is one variable in a clinical decision. The other variables (your medical history, current medications, any conditions that might affect suitability, your goals) are what a prescriber weighs before recommending a treatment and dose. That conversation can't be replaced by a checklist, and a real prescriber reviews it the same day you submit. Our clinical team assesses every consultation personally. If you have questions before you start, the FAQs cover the most common ones, and the appetite suppressant injection page goes deeper on the pharmacology for those who want it.

When you're ready to understand whether either medicine suits your situation, you can speak to our prescribers through a free consultation, with no obligation to proceed.